PHAT
Price
$7.01
Change
-$0.02 (-0.28%)
Updated
Oct 22 closing price
Capitalization
567.12M
7 days until earnings call
Intraday BUY SELL Signals
QCLS
Price
$0.53
Change
+$0.02 (+3.92%)
Updated
Oct 22 closing price
Capitalization
4.34M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PHAT vs QCLS

PHAT vs QCLS Comparison Chart in %
View a ticker or compare two or three
VS
PHAT vs. QCLS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a StrongBuy and QCLS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PHAT with price predictions
Oct 22, 2026

PHAT's RSI Indicator ascending out of oversold territory

The RSI Oscillator for PHAT moved out of oversold territory on October 07, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In 27 of the 29 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 62 cases where PHAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for PHAT just turned positive on October 08, 2026. Looking at past instances where PHAT's MACD turned positive, the stock continued to rise in 40 of 47 cases over the following month. The odds of a continued upward trend are 85%.

Following a +5.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHAT advanced for three days, in 242 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PHAT as a result. In 62 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for PHAT entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.647) is normal, around the industry mean (2.973). P/E Ratio (-5.608) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (2.511) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. PHAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for QCLS with price predictions
Oct 22, 2026

QCLS's RSI Oscillator ascending out of oversold territory

The RSI Indicator for QCLS moved out of oversold territory on October 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In 36 of the 40 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for QCLS just turned positive on September 24, 2026. Looking at past instances where QCLS's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.

Following a +5.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where QCLS advanced for three days, in 154 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QCLS as a result. In 90 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QCLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for QCLS entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.272) is normal, around the industry mean (-7.468). P/E Ratio (0.003) is within average values for comparable stocks, (-3.030). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (51.774).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. QCLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QCLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

FUNDAMENTALS RATINGS
PHAT vs QCLS: Fundamental Ratings
PHAT
QCLS
OUTLOOK RATING
1..100
2894
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
26
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8296
P/E GROWTH RATING
1..100
1496
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHAT's Valuation (17) in the null industry is in the same range as QCLS (26). This means that PHAT’s stock grew similarly to QCLS’s over the last 12 months.

PHAT's Profit vs Risk Rating (100) in the null industry is in the same range as QCLS (100). This means that PHAT’s stock grew similarly to QCLS’s over the last 12 months.

QCLS's SMR Rating (99) in the null industry is in the same range as PHAT (100). This means that QCLS’s stock grew similarly to PHAT’s over the last 12 months.

PHAT's Price Growth Rating (82) in the null industry is in the same range as QCLS (96). This means that PHAT’s stock grew similarly to QCLS’s over the last 12 months.

PHAT's P/E Growth Rating (14) in the null industry is significantly better than the same rating for QCLS (96). This means that PHAT’s stock grew significantly faster than QCLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHATQCLS
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (PHAT: $7.03 vs. QCLS: $0.51)
Brand notoriety: PHAT and QCLS are both not notable
PHAT represents the Biotechnology, while QCLS is part of the Computer Processing Hardware industry
Current volume relative to the 65-day Moving Average: PHAT: 55% vs. QCLS: 2%
Market capitalization -- PHAT: $567.12M vs. QCLS: $4.34M
PHAT [@Biotechnology] is valued at $567.12M. QCLS’s [@Computer Processing Hardware] market capitalization is $4.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The market cap for tickers in the [@Computer Processing Hardware] industry ranges from $1.78M to $308.93B. The average market capitalization across the [@Biotechnology] industry is $2.18B. The average market capitalization across the [@Computer Processing Hardware] industry is $27.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 2 FA rating(s) are green while QCLS’s FA Score has 1 green FA rating(s).

  • PHAT’s FA Score: 2 green, 3 red.
  • QCLS’s FA Score: 1 green, 4 red.
According to our system of comparison, PHAT is a better buy in the long-term than QCLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 6 TA indicator(s) are bullish while QCLS’s TA Score has 3 bullish TA indicator(s).

  • PHAT’s TA Score: 6 bullish, 2 bearish.
  • QCLS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than QCLS.

Price Growth

PHAT (@Biotechnology) experienced а -5.00% price change this week, while QCLS (@Computer Processing Hardware) price change was -5.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

The average weekly price growth across all stocks in the @Computer Processing Hardware industry was -5.00%. For the same industry, the average monthly price growth was -18.34%, and the average quarterly price growth was -2.11%.

Reported Earning Dates

PHAT is expected to report earnings on Oct 29, 2026.

QCLS is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Computer Processing Hardware (-5.00% weekly)

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

View a ticker or compare two or three
PHAT
Daily Signal:
Gain/Loss:
QCLS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with ALNY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-0.28%
ALNY - PHAT
45%
Loosely correlated
+0.97%
QCLS - PHAT
39%
Loosely correlated
+3.50%
ATRA - PHAT
36%
Loosely correlated
+0.86%
KURA - PHAT
32%
Poorly correlated
-0.20%
STOK - PHAT
32%
Poorly correlated
+0.08%
More

QCLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, QCLS has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if QCLS jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QCLS
1D Price
Change %
QCLS100%
+3.50%
ARTV - QCLS
47%
Loosely correlated
-4.47%
COGT - QCLS
39%
Loosely correlated
-0.38%
PHAT - QCLS
39%
Loosely correlated
-0.28%
TVGN - QCLS
36%
Loosely correlated
+0.30%
QUBT - QCLS
33%
Poorly correlated
-3.37%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIVB28.151.40
+5.23%
Civista Bancshares
AAP46.692.17
+4.87%
Advance Auto Parts
TME8.600.16
+1.90%
Tencent Music Entertainment Group
FNWB9.650.11
+1.15%
First Northwest Bancorp
CANF1.83-0.06
-3.15%
Can-Fite Biopharma Ltd